BZG: Spirometer, Diagnostic
What it covers
A diagnostic spirometer is a device used in pulmonary function testing to measure the volume of gas moving in or out of a patient's lungs.
The identification in 21 CFR 868.1840, diagnostic spirometer. FDA gives BZG no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K251777 | MESI mTABLET SPIRO | Mesi D.O.O. | Mar 2, 2026 | Traditional |
| K241843 | TD-7301 Spirometer (TD-7301) | Gostar Co., Ltd. | Nov 20, 2024 | Traditional |
| K231416 | Air Next (NVD-02) | Nuvoair AB | Jan 18, 2024 | Traditional |
| K230501 | Spirobank Oxi | Mir Medical International Research USA | Dec 15, 2023 | Traditional |
| K230178 | EasyOne Sky Spirometer | Ndd Medizintechnik AG | Oct 19, 2023 | Traditional |
| K222525 | Alveoair Digital Spirometer | Roundworks Technologies Private Limited | Aug 28, 2023 | Traditional |
| K222443 | Air Smart Extra Spirometer | Feellife Health, Inc. | Aug 9, 2023 | Traditional |
| K213754 | SpiroHome Personal, SpiroHome Clinic | Inofab Saglik Teknolojileri A.S | Jun 12, 2023 | Traditional |
| K213872 | ComPAS2 | Morgan Scientific, Inc. | Jul 15, 2022 | Traditional |
| K212938 | Vitalograph Model 6000 Alpha | Vitalograph Ireland, Ltd. | Jan 26, 2022 | Traditional |
Clearances by year
48 BZG 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 1 | 265 |
| 2024 | 2 | 197 |
| 2023 | 5 | 362 |
| 2022 | 2 | 174 |
| 2021 | 1 | 371 |
| 2020 | 5 | 126 |
| 2019 | 3 | 146 |
| 2018 | 1 | 192 |
| 2017 | 2 | 171 |
| 2016 | 4 | 235 |
| 2015 | 5 | 273 |
| 2014 | 5 | 154 |
| 2013 | 3 | 266 |
| 2012 | 3 | 59 |
| 2011 | 6 | 278 |
Who submits
34 applicants cleared a BZG device since 2011. 40% of the clearances went to applicants in United States, then Ireland (15%), Germany (10%) and Switzerland (4%). By type: Traditional 85% and Special 15%. 1 went through a third-party review organization.
| Applicant | Clearances since 2011 |
|---|---|
| Vitalograph (Ireland) , Ltd. | 4 |
| Carefusion Germany 234 GmbH | 3 |
| Vitalograph Ireland, Ltd. | 3 |
| Eresearch Technology | 2 |
| Medikro OY | 2 |
| Mir Medical Intl. Research Srl | 2 |
| Monitored Therapeutics, Inc. | 2 |
| Morgan Scientific, Inc. | 2 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 868.1840.
Standards
21 CFR 868.1840 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent BZG clearances declared.
Ask about BZG
Questions about BZG
What is FDA product code BZG?
Product code BZG, “Spirometer, Diagnostic” in FDA's classification database, is a Class II device type under 21 CFR 868.1840 (diagnostic spirometer), reviewed by FDA's Anesthesiology panel. FDA's 510(k) database lists 228 clearances under BZG, 48 of them since 2011.
How many 510(k) clearances are there under BZG?
FDA’s 510(k) database listed 228 clearances under BZG as of Oct 29, 2026, 48 of them decided since 2011; the most recent decision was Mar 2, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a BZG 510(k)?
For the 2 BZG clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 206 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most BZG clearances?
Since 2011: Vitalograph (Ireland) , Ltd. (4), Carefusion Germany 234 GmbH (3), Vitalograph Ireland, Ltd. (3), Eresearch Technology (2) and Medikro OY (2). 34 applicants have cleared a BZG device in that time.